GlassScriptPhysician profile
Thomas C Greaves
NPI 1982086633
$2,510.66
in general payments reported to CMS, 2019-2025
27 companies · $73.23 in 2025
The $73.23 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $310 · 2021: $619 · 2022: $489 · 2023: $324 · 2024: $344 · 2025: $73.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $777.91 | 2019-2024 | |
| Coopersurgical, INC. | $171.73 | 2020-2023 | Paragard T 380a |
| Organon LLC | $150.72 | 2021-2024 | |
| Applied Medical Resources Corporation | $136.24 | 2022 | |
| Biogen, INC. | $129.02 | 2024-2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $124.96 | 2019 | |
| Pfizer INC. | $99.60 | 2022-2024 | |
| Novo Nordisk INC | $94.63 | 2020-2024 | Wegovy |
| Sumitomo Pharma America, INC. | $93.77 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $84.91 | 2020-2023 | |
| Myovant Sciences INC. | $74.26 | 2022 | |
| Astellas Pharma US INC | $70.21 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $69.77 | 2023-2025 | |
| Daiichi Sankyo INC. | $69.74 | 2019-2021 | |
| Therapeuticsmd, INC. | $58.14 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $40.50 | 2019-2022 | |
| Agile Therapeutics, INC. | $40.33 | 2023-2024 | Twirla |
| Alydia Health | $38.22 | 2021 | |
| Medtronic, INC. | $31.25 | 2021-2023 | Truclear |
| Exeltis, USA INC. | $26.67 | 2022 | |
| Roche Diagnostics Corporation | $24.70 | 2021 | |
| Olympus America INC. | $21.35 | 2023 | Olympus |
| Amarin Pharma, INC. | $20.77 | 2021 | |
| Gynesonics, INC. | $16.25 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $15.67 | 2020 | |
| Allergan, INC. | $15.41 | 2020 | |
| Avion Pharmaceuticals | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Greaves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.